Twelve Bio appoints Gita Dittmar as Executive Chairman of the Board of Directors
– DENMARK, Copenhagen – Twelve Bio, a gene-editing company pioneering the therapeutic application of CRISPR-Cas12 medicines, today announced the appointment of Gita Dittmar, DVM as Executive Chairman of the Board of Directors.…